Please login to the form below

Not currently logged in
Email:
Password:

Novartis’ Nicola Redfern joins Celgene to head UK market access

Role will focus on ensuring stakeholders keep receiving relevant product information as the NHS undergoes reforms

Nicola Redfern - CelgeneNicola Redfern has been appointed director of market access at Celgene for the UK and Ireland.

Redfern joins Celgene from Novartis where she was director of communications and external affairs for the Swiss pharma firm's oncology business unit.

At Novartis, she was responsible for health economics and outcomes research, communications, patient advocacy, government affairs and leadership of the field-based NHS development team, and Redfern will fill a similar role at Celgene focusing on the changing NHS landscape.

“I am very excited to join Celgene and bring my experience to the market access team to help continue the great work Celgene has been undertaking to improve patient outcome,” she said.

“There is a true need for new innovative medicines and I look forward to working with the team towards helping more patients receive access to these important treatments.”

Prior to joining Novartis in 2003, Redfern spent four years at Sanofi. This included spells as senior product manager and head of medical education. She has also worked in sales for MSD, Procter & Gamble and Pierre Fabrine.

Samantha Pearce, general manager of Celgene UK and Ireland, said: “We are delighted to welcome Nicola to our growing team at Celgene. Her role reinforces our continued commitment to making our treatments available and accessible to all that need them, particularly given the evolving policy environment.”

18th June 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics